| Year |
Citation |
Score |
| 2024 |
Milioto C, Carcolé M, Giblin A, Coneys R, Attrebi O, Ahmed M, Harris SS, Lee BI, Yang M, Ellingford RA, Nirujogi RS, Biggs D, Salomonsson S, Zanovello M, de Oliveira P, ... ... Busche MA, et al. PolyGR and polyPR knock-in mice reveal a conserved neuroprotective extracellular matrix signature in C9orf72 ALS/FTD neurons. Nature Neuroscience. PMID 38424324 DOI: 10.1038/s41593-024-01589-4 |
0.398 |
|
| 2021 |
Mensch M, Dunot J, Yishan SM, Harris SS, Blistein A, Avdiu A, Pousinha PA, Giudici C, Busche MA, Jedlicka P, Willem M, Marie H. Aη-α and Aη-β peptides impair LTP ex vivo within the low nanomolar range and impact neuronal activity in vivo. Alzheimer's Research & Therapy. 13: 125. PMID 34238366 DOI: 10.1186/s13195-021-00860-1 |
0.494 |
|
| 2021 |
Maestú F, de Haan W, Busche MA, DeFelipe J. Neuronal excitation/inhibition imbalance: core element of a translational perspective on Alzheimer pathophysiology. Ageing Research Reviews. 69: 101372. PMID 34029743 DOI: 10.1016/j.arr.2021.101372 |
0.49 |
|
| 2020 |
Busche MA, Hyman BT. Synergy between amyloid-β and tau in Alzheimer's disease. Nature Neuroscience. PMID 32778792 DOI: 10.1038/S41593-020-0687-6 |
0.475 |
|
| 2020 |
Harris SS, Wolf F, De Strooper B, Busche MA. Tipping the Scales: Peptide-Dependent Dysregulation of Neural Circuit Dynamics in Alzheimer's Disease. Neuron. PMID 32579881 DOI: 10.1016/J.Neuron.2020.06.005 |
0.49 |
|
| 2020 |
Pigoni M, Hsia HE, Hartmann J, Rudan Njavro J, Shmueli MD, Müller SA, Güner G, Tüshaus J, Kuhn PH, Kumar R, Gao P, Tran ML, Ramazanov B, Blank B, Hipgrave Ederveen AL, ... ... Busche MA, et al. Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3. The Embo Journal. e103457. PMID 32567721 DOI: 10.15252/Embj.2019103457 |
0.417 |
|
| 2019 |
Busche MA. Tau suppresses neuronal activity in vivo, even before tangles form. Brain : a Journal of Neurology. 142: 843-846. PMID 30946472 DOI: 10.1093/brain/awz060 |
0.476 |
|
| 2019 |
Busche MA, Wegmann S, Dujardin S, Commins C, Schiantarelli J, Klickstein N, Kamath TV, Carlson GA, Nelken I, Hyman BT. Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo. Nature Neuroscience. 22: 57-64. PMID 30559471 DOI: 10.1038/S41593-018-0289-8 |
0.623 |
|
| 2018 |
Zott B, Busche MA, Sperling RA, Konnerth A. What Happens with the Circuit in Alzheimer's Disease in Mice and Humans? Annual Review of Neuroscience. 41: 277-297. PMID 29986165 DOI: 10.1146/annurev-neuro-080317-061725 |
0.735 |
|
| 2018 |
Busche MA. In Vivo Two-Photon Calcium Imaging of Hippocampal Neurons in Alzheimer Mouse Models. Methods in Molecular Biology (Clifton, N.J.). 1750: 341-351. PMID 29512084 DOI: 10.1007/978-1-4939-7704-8_23 |
0.58 |
|
| 2017 |
Keskin AD, Kekuš M, Adelsberger H, Neumann U, Shimshek DR, Song B, Zott B, Peng T, Förstl H, Staufenbiel M, Nelken I, Sakmann B, Konnerth A, Busche MA. BACE inhibition-dependent repair of Alzheimer's pathophysiology. Proceedings of the National Academy of Sciences of the United States of America. PMID 28739891 DOI: 10.1073/Pnas.1708106114 |
0.735 |
|
| 2016 |
Busche MA, Konnerth A. Impairments of neural circuit function in Alzheimer's disease. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 371. PMID 27377723 DOI: 10.1098/rstb.2015.0429 |
0.738 |
|
| 2016 |
Busche MA, Staufenbiel M, Willem M, Haass C, Förstl H. [Mechanisms of Alzheimer's disease : Neuronal hyperactivity and hypoactivity as new therapeutic targets]. Der Nervenarzt. PMID 26781314 DOI: 10.1007/S00115-015-0041-5 |
0.588 |
|
| 2015 |
Busche MA, Grienberger C, Keskin AD, Song B, Neumann U, Staufenbiel M, Förstl H, Konnerth A. Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models. Nature Neuroscience. PMID 26551546 DOI: 10.1038/Nn.4163 |
0.694 |
|
| 2015 |
Busche MA, Kekuš M, Adelsberger H, Noda T, Förstl H, Nelken I, Konnerth A. Rescue of long-range circuit dysfunction in Alzheimer's disease models. Nature Neuroscience. 18: 1623-30. PMID 26457554 DOI: 10.1038/nn.4137 |
0.636 |
|
| 2015 |
Willem M, Tahirovic S, Busche MA, Ovsepian SV, Chafai M, Kootar S, Hornburg D, Evans LD, Moore S, Daria A, Hampel H, Müller V, Giudici C, Nuscher B, Wenninger-Weinzierl A, et al. η-Secretase processing of APP inhibits neuronal activity in the hippocampus. Nature. PMID 26322584 DOI: 10.1038/Nature14864 |
0.639 |
|
| 2015 |
Busche MA, Konnerth A. Neuronal hyperactivity - A key defect in Alzheimer's disease? Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 37: 624-32. PMID 25773221 DOI: 10.1002/bies.201500004 |
0.746 |
|
| 2014 |
Busche MA, Kekus M, Adelsberger H, Förstl H, Nelken I, Konnerth A. O3-05-04: LARGE-SCALE IMAGING OF NEURONAL NETWORK DYNAMICS IN MOUSE MODELS OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P218-P218. DOI: 10.1016/j.jalz.2014.04.296 |
0.627 |
|
| 2012 |
Busche MA, Chen X, Henning HA, Reichwald J, Staufenbiel M, Sakmann B, Konnerth A. Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 109: 8740-5. PMID 22592800 DOI: 10.1073/Pnas.1206171109 |
0.755 |
|
| 2008 |
Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, Haass C, Staufenbiel M, Konnerth A, Garaschuk O. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science (New York, N.Y.). 321: 1686-9. PMID 18802001 DOI: 10.1126/Science.1162844 |
0.741 |
|
| 2008 |
Eichhoff G, Busche MA, Garaschuk O. In vivo calcium imaging of the aging and diseased brain. European Journal of Nuclear Medicine and Molecular Imaging. 35: S99-106. PMID 18193219 DOI: 10.1007/s00259-007-0709-6 |
0.623 |
|
| Show low-probability matches. |